- call +1-201-465-4211
- email sales@mrinsights.biz
Scope of the Report:
This report focuses on the Anti-Malarial Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Anti-malarial drugs (also called anti-malarials) are medications used for the treatment and prevention of malaria infection.
On the one hand, they are used for routine intermittent treatment of specific groups in endemic regions. On the other, the drug can prevent the infection in individuals who travel or visit a malaria-endemic region
The worldwide market for Anti-Malarial Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
GlaxoSmithKline
Ranbaxy
Zydus Cadila
Alvizia
Bayer
Ipca
Merck
F. Hoffmann-La Roche
Novartis
Pfizer
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Plasmodium Falciparum
Plasmodium Vivax
Plasmodium Malariae
Plasmodium Ovale
Market Segment by Applications, can be divided into
Hospital Pharmacy
Retail Pharmacy
E-Commerce
Others
There are 15 Chapters to deeply display the global Anti-Malarial Drug market.
Chapter 1, to describe Anti-Malarial Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Anti-Malarial Drug, with sales, revenue, and price of Anti-Malarial Drug, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Anti-Malarial Drug, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Anti-Malarial Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Anti-Malarial Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Anti-Malarial Drug Introduction
1.2 Market Analysis by Type
1.2.1 Plasmodium Falciparum
1.2.2 Plasmodium Vivax
1.2.3 Plasmodium Malariae
1.2.4 Plasmodium Ovale
1.3 Market Analysis by Applications
1.3.1 Hospital Pharmacy
1.3.2 Retail Pharmacy
1.3.3 E-Commerce
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 Business Overview
2.1.2 Anti-Malarial Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GlaxoSmithKline Anti-Malarial Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Ranbaxy
2.2.1 Business Overview
2.2.2 Anti-Malarial Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Ranbaxy Anti-Malarial Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Zydus Cadila
2.3.1 Business Overview
2.3.2 Anti-Malarial Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Zydus Cadila Anti-Malarial Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Alvizia
2.4.1 Business Overview
2.4.2 Anti-Malarial Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Alvizia Anti-Malarial Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Bayer
2.5.1 Business Overview
2.5.2 Anti-Malarial Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bayer Anti-Malarial Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Ipca
2.6.1 Business Overview
2.6.2 Anti-Malarial Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Ipca Anti-Malarial Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Merck
2.7.1 Business Overview
2.7.2 Anti-Malarial Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck Anti-Malarial Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 F. Hoffmann-La Roche
2.8.1 Business Overview
2.8.2 Anti-Malarial Drug Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 F. Hoffmann-La Roche Anti-Malarial Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Novartis
2.9.1 Business Overview
2.9.2 Anti-Malarial Drug Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Novartis Anti-Malarial Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Pfizer
2.10.1 Business Overview
2.10.2 Anti-Malarial Drug Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Pfizer Anti-Malarial Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Anti-Malarial Drug Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Anti-Malarial Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Anti-Malarial Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Anti-Malarial Drug Manufacturer Market Share in 2017
3.3.2 Top 6 Anti-Malarial Drug Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Anti-Malarial Drug Market Analysis by Regions
4.1 Global Anti-Malarial Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Anti-Malarial Drug Sales and Market Share by Regions (2013-2018)
4.1.2 Global Anti-Malarial Drug Revenue and Market Share by Regions (2013-2018)
4.2 North America Anti-Malarial Drug Sales and Growth Rate (2013-2018)
4.3 Europe Anti-Malarial Drug Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Anti-Malarial Drug Sales and Growth Rate (2013-2018)
4.5 South America Anti-Malarial Drug Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Anti-Malarial Drug Sales and Growth Rate (2013-2018)
5 North America Anti-Malarial Drug by Countries
5.1 North America Anti-Malarial Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Anti-Malarial Drug Sales and Market Share by Countries (2013-2018)
5.1.2 North America Anti-Malarial Drug Revenue and Market Share by Countries (2013-2018)
5.2 United States Anti-Malarial Drug Sales and Growth Rate (2013-2018)
5.3 Canada Anti-Malarial Drug Sales and Growth Rate (2013-2018)
5.4 Mexico Anti-Malarial Drug Sales and Growth Rate (2013-2018)
6 Europe Anti-Malarial Drug by Countries
6.1 Europe Anti-Malarial Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Anti-Malarial Drug Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Anti-Malarial Drug Revenue and Market Share by Countries (2013-2018)
6.2 Germany Anti-Malarial Drug Sales and Growth Rate (2013-2018)
6.3 UK Anti-Malarial Drug Sales and Growth Rate (2013-2018)
6.4 France Anti-Malarial Drug Sales and Growth Rate (2013-2018)
6.5 Russia Anti-Malarial Drug Sales and Growth Rate (2013-2018)
6.6 Italy Anti-Malarial Drug Sales and Growth Rate (2013-2018)
7 Asia-Pacific Anti-Malarial Drug by Countries
7.1 Asia-Pacific Anti-Malarial Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Anti-Malarial Drug Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Anti-Malarial Drug Revenue and Market Share by Countries (2013-2018)
7.2 China Anti-Malarial Drug Sales and Growth Rate (2013-2018)
7.3 Japan Anti-Malarial Drug Sales and Growth Rate (2013-2018)
7.4 Korea Anti-Malarial Drug Sales and Growth Rate (2013-2018)
7.5 India Anti-Malarial Drug Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Anti-Malarial Drug Sales and Growth Rate (2013-2018)
8 South America Anti-Malarial Drug by Countries
8.1 South America Anti-Malarial Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Anti-Malarial Drug Sales and Market Share by Countries (2013-2018)
8.1.2 South America Anti-Malarial Drug Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Anti-Malarial Drug Sales and Growth Rate (2013-2018)
8.3 Argentina Anti-Malarial Drug Sales and Growth Rate (2013-2018)
8.4 Colombia Anti-Malarial Drug Sales and Growth Rate (2013-2018)
9 Middle East and Africa Anti-Malarial Drug by Countries
9.1 Middle East and Africa Anti-Malarial Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Anti-Malarial Drug Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Anti-Malarial Drug Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Anti-Malarial Drug Sales and Growth Rate (2013-2018)
9.3 UAE Anti-Malarial Drug Sales and Growth Rate (2013-2018)
9.4 Egypt Anti-Malarial Drug Sales and Growth Rate (2013-2018)
9.5 Nigeria Anti-Malarial Drug Sales and Growth Rate (2013-2018)
9.6 South Africa Anti-Malarial Drug Sales and Growth Rate (2013-2018)
10 Global Anti-Malarial Drug Market Segment by Type
10.1 Global Anti-Malarial Drug Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Anti-Malarial Drug Sales and Market Share by Type (2013-2018)
10.1.2 Global Anti-Malarial Drug Revenue and Market Share by Type (2013-2018)
10.2 Plasmodium Falciparum Sales Growth and Price
10.2.1 Global Plasmodium Falciparum Sales Growth (2013-2018)
10.2.2 Global Plasmodium Falciparum Price (2013-2018)
10.3 Plasmodium Vivax Sales Growth and Price
10.3.1 Global Plasmodium Vivax Sales Growth (2013-2018)
10.3.2 Global Plasmodium Vivax Price (2013-2018)
10.4 Plasmodium Malariae Sales Growth and Price
10.4.1 Global Plasmodium Malariae Sales Growth (2013-2018)
10.4.2 Global Plasmodium Malariae Price (2013-2018)
10.5 Plasmodium Ovale Sales Growth and Price
10.5.1 Global Plasmodium Ovale Sales Growth (2013-2018)
10.5.2 Global Plasmodium Ovale Price (2013-2018)
11 Global Anti-Malarial Drug Market Segment by Application
11.1 Global Anti-Malarial Drug Sales Market Share by Application (2013-2018)
11.2 Hospital Pharmacy Sales Growth (2013-2018)
11.3 Retail Pharmacy Sales Growth (2013-2018)
11.4 E-Commerce Sales Growth (2013-2018)
11.5 Others Sales Growth (2013-2018)
12 Anti-Malarial Drug Market Forecast (2018-2023)
12.1 Global Anti-Malarial Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Anti-Malarial Drug Market Forecast by Regions (2018-2023)
12.2.1 North America Anti-Malarial Drug Market Forecast (2018-2023)
12.2.2 Europe Anti-Malarial Drug Market Forecast (2018-2023)
12.2.3 Asia-Pacific Anti-Malarial Drug Market Forecast (2018-2023)
12.2.4 South America Anti-Malarial Drug Market Forecast (2018-2023)
12.2.5 Middle East and Africa Anti-Malarial Drug Market Forecast (2018-2023)
12.3 Anti-Malarial Drug Market Forecast by Type (2018-2023)
12.3.1 Global Anti-Malarial Drug Sales Forecast by Type (2018-2023)
12.3.2 Global Anti-Malarial Drug Market Share Forecast by Type (2018-2023)
12.4 Anti-Malarial Drug Market Forecast by Application (2018-2023)
12.4.1 Global Anti-Malarial Drug Sales Forecast by Application (2018-2023)
12.4.2 Global Anti-Malarial Drug Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Anti-Malarial Drug Picture
Table Product Specifications of Anti-Malarial Drug
Figure Global Sales Market Share of Anti-Malarial Drug by Types in 2017
Ta
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
